Dynavax Technologies | Custo De Mercadoria Vendida

Cost Of Sales Alterar Data
AbbVie USD 4.09B 181M 2024-03
Adma Biologics USD 42.77M 50K 2024-03
Amgen USD 3.2B 88M 2024-03
AstraZeneca USD 2.22B 63M 2024-03
Biogen USD 542.2M 76.1M 2024-03
BioMarin Pharmaceutical USD 125.18M 10.3M 2024-03
Bristol-Myers Squibb USD 2.93B 225M 2024-03
Dynavax Technologies USD 10.97M 2.28M 2024-03
Gilead Sciences USD 1.55B 59M 2024-03
Glaxosmithkline GBP 1.97B 363M 2024-03
Merck USD 3.54B 200M 2024-03
Neurocrine Biosciences USD 7.5M 3.7M 2024-03
Novartis USD 3.1B 109M 2024-03
Pfizer USD 3.38B 3.29B 2024-03
Regeneron Pharmaceuticals USD 433.8M 83.2M 2024-03
Roche Holding CHF 7.62B 1.33B 2023-06
Sarepta Therapeutics USD 50.56M 13.53M 2024-03
TG Therapeutics USD 5.44M 2.41M 2024-03
Vertex Pharmaceuticals USD 342.6M 23.9M 2024-03



Dynavax Technologies Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.